No Evidence of Delayed Parasite Clearance after Oral Artesunate Treatment of Uncomplicated Falciparum Malaria in Mali
Authors:
- Amelia W. MaigaAMAmelia W. Maiga
- Kassim SanogoKSKassim Sanogo
- Christopher V. PloweCPChristopher V. Plowe
- Sekou ToureSTSekou Toure
- Abdoulaye A. DjimdeADAbdoulaye A. Djimde
- Souleymane DamaSDSouleymane Dama
- Issaka SagaraIssaka Sagara
- Bakary FofanaBFBakary Fofana
- Bakary SidibeBSBakary Sidibe
- Antoine DaraADAntoine Dara
- Mahamadou A. TheraMTMahamadou A. Thera
- Demba DembeleDDDemba Dembele
Open Access
- 2 July 2012
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 87 (1) , 23-28
Abstract
Plasmodium falciparum resistance to artemisinins by delayed parasite clearance is present in Southeast Asia. Scant data on parasite clearance after artemisinins are available from Africa, where transmission is high, burden is greatest, and artemisinin use is being scaled up. Children 1–10 years of age with uncomplicated malaria were treated with 7 days of artesunate and followed for 28 days. Blood smears were done every 8 hours until negative by light microscopy. Results were compared with a similar study conducted in the same village in 2002–2004. The polymerase chain reaction-corrected cure rate was 100%, identical to 2002–2004. By 24 hours after treatment initiation, 37.0% of participants had cleared parasitemia, compared with 31.9% in 2002–2004 (P = 0.5). The median parasite clearance time was 32 hours. Only one participant still had parasites at 48 hours and no participant presented parasitemia at 72 hours. Artesunate was highly efficacious, with no evidence of delayed parasite clearance. We provide baseline surveillance data for the emergence or dissemination of P. falciparum resistance in sub-Saharan Africa.Keywords
This publication has 23 references indexed in Scilit:
- Artesunate Dose Escalation for the Treatment of Uncomplicated Malaria in a Region of Reported Artemisinin Resistance: A Randomized Clinical TrialPLOS ONE, 2011
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- Access to artemisinin combination therapy for malaria in remote areas of CambodiaMalaria Journal, 2008
- Efficacy, Safety, and Selection of Molecular Markers of Drug Resistance by Two ACTs in MaliThe American Journal of Tropical Medicine and Hygiene, 2008
- Pharmacologic Advances in the Global Control and Treatment of Malaria: Combination Therapy and ResistanceClinical Pharmacology & Therapeutics, 2007
- PFMDR1 AND IN VIVO RESISTANCE TO ARTESUNATE-MEFLOQUINE IN FALCIPARUM MALARIA ON THE CAMBODIAN–THAI BORDERThe American Journal of Tropical Medicine and Hygiene, 2007
- RECRUDESCENCE IN ARTESUNATE-TREATED PATIENTS WITH FALCIPARUM MALARIA IS DEPENDENT ON PARASITE BURDEN NOT ON PARASITE FACTORSThe American Journal of Tropical Medicine and Hygiene, 2003
- Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy?The American Journal of Tropical Medicine and Hygiene, 2001
- Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.2000
- Effect of paracetamol on parasite clearance time in Plasmodium falciparum malariaThe Lancet, 1997